Physician profile
Lawrence Morton
NPI 1033138698
$17,116.54
in general payments reported to CMS, 2019-2025
18 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,413 · 2020: $1,669 · 2021: $687 · 2022: $607 · 2023: $6,955 · 2024: $2,261 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,554 · Food and Beverage: $2,444 · Travel and Lodging: $1,436 · Honoraria: $1,290 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,554.00 |
| Food and Beverage | $2,444.38 |
| Travel and Lodging | $1,435.67 |
| Honoraria | $1,290.00 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $6,731.78 | 2020-2025 | Valtoco |
| Greenwich Biosciences, INC. | $4,196.82 | 2019-2020 | |
| Ucb, INC. | $1,950.79 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Nobelpharma America, LLC | $1,290.00 | 2024 | |
| Eisai INC. | $1,121.36 | 2019-2021 | |
| Sk Life Science, INC. | $580.32 | 2020-2023 | Xcopri |
| Livanova USA, INC. | $440.03 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Upsher-Smith Laboratories LLC | $165.25 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $136.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $134.43 | 2024 | Koselugo |
| Biomarin Pharmaceutical INC. | $109.91 | 2022 | |
| Immedica Pharma US, INC. | $82.50 | 2022 | |
| Jazz Pharmaceuticals INC. | $77.16 | 2025 | |
| Acadia Pharmaceuticals INC | $45.34 | 2024-2025 | Daybue |
| Neuropace, INC. | $37.79 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.